Comparative Pharmacology
Head-to-head clinical analysis: KABIVEN IN PLASTIC CONTAINER versus PERIKABIVEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: KABIVEN IN PLASTIC CONTAINER versus PERIKABIVEN IN PLASTIC CONTAINER.
KABIVEN IN PLASTIC CONTAINER vs PERIKABIVEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Kabiven is a parenteral nutrition formulation that provides a balanced mixture of amino acids, dextrose, and lipids to meet nutritional requirements. The amino acids serve as building blocks for protein synthesis, dextrose provides a carbohydrate source for energy, and lipids supply essential fatty acids and additional energy. Electrolytes are included to maintain fluid and electrolyte balance.
Perikabiven provides a balanced mixture of amino acids, electrolytes, dextrose, and lipids for parenteral nutrition. Amino acids serve as building blocks for protein synthesis, dextrose provides glucose for energy, and lipids supply essential fatty acids and a concentrated energy source. Electrolytes maintain osmotic balance and support biochemical reactions.
Intravenous infusion. Adult dose based on nutritional needs: typically 0.8-1.5 g amino acids/kg/day, 0.8-1.5 g lipids/kg/day, and 2-4 g dextrose/kg/day. Maximum infusion rate: 1.7 mL/kg/hour (Kabiven Peripher) or 2.6 mL/kg/hour (Kabiven Central).
Intravenous administration: usual adult dose is 1.5 to 2.0 g amino acids per kg per day, corresponding to 25-30 mL/kg/day of Perikabiven, with a maximum infusion rate of 2.5 mL/kg/hour.
None Documented
None Documented
Variable; amino acids: 0.5–1 h; lipids: 0.5–1 h (intralipid clearance); glucose: rapid. No true terminal half-life as a mixture.
Amino acids: ~0.5-1 hour (rapid clearance due to metabolic incorporation and urinary elimination). Lipids: terminal elimination half-life of ~30 minutes to 1.5 hours for triglycerides, with longer half-life for essential fatty acids (days to weeks due to incorporation into cell membranes). Clinical context: rapid clearance from plasma with continuous infusion.
Renal: <3% unchanged; primarily metabolized via protein catabolism; nitrogen excretion is renal (urea, ammonia); fat emulsion components are cleared by the reticuloendothelial system and metabolized. Biliary/fecal: negligible.
Renal (primarily as ammonium and urea) and biliary (fecal loss of unabsorbed lipids). The amino acids, dextrose, and electrolytes are eliminated via renal excretion; lipids are metabolized and eliminated as CO2 and water. Approximately 20-30% of the lipid dose is excreted renally as metabolites, with <5% excreted unchanged.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition